Lisa De Francesco is SVP, IR & Corp. Affairs of INTERCEPT PHARMACEUTICALS, INC.. Currently has a direct ownership of 10,308 shares of ICPT, which is worth approximately $0. The most recent transaction as insider was on Dec 31, 2021, when has been sold 542 shares (Common Stock) at a price of $16.29 per share, resulting in proceeds of $8,829. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10.3K
0% 3M change
0% 12M change
Total Value Held $0

Lisa DeFrancesco Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 31 2021
SELL
Payment of exercise price or tax liability
$8,829 $16.29 p/Share
542 Reduced 5.0%
10,308 Common Stock
Sep 30 2021
SELL
Payment of exercise price or tax liability
$3,029 $14.85 p/Share
204 Reduced 1.85%
10,850 Common Stock
Sep 01 2021
SELL
Payment of exercise price or tax liability
$8,097 $15.05 p/Share
538 Reduced 4.64%
11,054 Common Stock
LD

Lisa De Francesco

SVP, IR & Corp. Affairs
New York, NY

Track Institutional and Insider Activities on ICPT

Follow INTERCEPT PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ICPT shares.

Notify only if

Insider Trading

Get notified when an Intercept Pharmaceuticals, Inc. insider buys or sells ICPT shares.

Notify only if

News

Receive news related to INTERCEPT PHARMACEUTICALS, INC.

Track Activities on ICPT